Medicine and Dentistry
Rufinamide
100%
Stiripentol
100%
Clobazam
100%
Eslicarbazepine
100%
Brivaracetam
100%
Randomized Controlled Trial
100%
Cannabidiol
100%
Sodium Valproate
100%
Vigabatrin
100%
Ethosuximide
100%
Lacosamide
100%
Fenfluramine
100%
Levetiracetam
100%
Pregabalin
100%
Carbamazepine
100%
Diseases
100%
Oxcarbazepine
100%
Decreased Appetite
100%
Topiramate
100%
Adverse Effect
100%
Lamotrigine
100%
Pediatrics
100%
Felbamate
100%
Perampanel
100%
Zonisamide
100%
Neurology
100%
Pharmacology, Toxicology and Pharmaceutical Science
Eslicarbazepine
100%
Ethosuximide
100%
Clobazam
100%
Sodium Valproate
100%
Lacosamide
100%
Perampanel
100%
Stiripentol
100%
Pregabalin
100%
Vigabatrin
100%
Felbamate
100%
Levetiracetam
100%
Diseases
100%
Oxcarbazepine
100%
Brivaracetam
100%
Rufinamide
100%
Decreased Appetite
100%
Topiramate
100%
Fenfluramine
100%
Zonisamide
100%
Carbamazepine
100%
Lamictal
100%
Randomized Controlled Trial
100%
Cannabidiol
100%
Keyphrases
Antiseizure Medication
100%
Weight Gain
37%
Eslicarbazepine Acetate
12%
Weight Concerns
12%
Vigabatrin
12%
Stiripentol
12%
Normal Weight
12%
Normal Growth
12%
Therapeutic Study
12%
Weight Loss
12%
Treatment Adherence
12%
Childhood Epilepsy
12%
MEDLINE
12%
Underlying Disease
12%
Felbamate
12%
Decreased Appetite
12%
Randomized Controlled Trial
12%
Valproic Acid
12%
Child Growth
12%
Levetiracetam
12%
Topiramate
12%
Brivaracetam
12%
Open-label Extension
12%
Treatment Regimen
12%
Carbamazepine
12%
Minimal Impact
12%
American Academy of Neurology
12%
Cannabidiol
12%
Pediatric Population
12%
Epilepsy
12%
Oxcarbazepine
12%
Ethosuximide
12%
Zonisamide
12%
Lamotrigine
12%
Pregabalin
12%
Fenfluramine
12%
Perampanel
12%
Rufinamide
12%
Lacosamide
12%
Clobazam
12%
Potential Adverse Effects
12%